Filing Flows › Repligen (RGEN) › Q1 2025
Repligen (RGEN) Q1 2025 earnings results (first quarter 2025)
10-Q filed Apr 29, 2025
Repligen (RGEN) reported revenue of $169M for the first quarter 2025 (Q1 2025), +10% from a year earlier and +1% from the quarter before. Operating margin was 3.9%, net earnings $5.8M (3.4% of revenue).
Repligen, Q1 2025: revenue $169M (+10% year over year), operating margin 3.9%, net earnings $5.8M, operating cash flow $15.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $169M | +1% | +10% |
| Operating profit | $6.6M | — | +75% |
| Net earnings | $5.8M | — | +77% |
| Operating cash flow | $15.0M | -62% | -66% |
| Free cash flow | $11.4M | -66% | -69% |
What changed
Revenue was $169.2M in Q1 2025, up 10% year over year and up 1% from the previous quarter. Product was the largest line at 100% of revenue. Product added $16.0M year over year (up 10%), 100% of the total change. Royalty declined 3%.
Operating profit was $6.6M, a 3.9% margin (up 1.4 points year over year). Of the extra revenue versus a year earlier, 18% reached operating profit, above the 2% margin then. Total costs grew 9% against revenue growth of 10%. The fastest-growing cost line was Research & development (+15%). Net earnings were $5.8M, up 77% year over year. The effective tax rate was 26.6%.
Operating cash flow was $15.0M (down 66% year over year), 257% of net earnings. Non-cash charges added back $18.7M of depreciation and amortization and $7.3M of share-based compensation. Working capital and other items used $16.8M. Capital expenditures of $3.6M left free cash flow of $11.4M.
Questions
What was Repligen's revenue in the first quarter 2025?
Repligen (RGEN) reported revenue of $169M for the first quarter 2025 (Q1 2025), +10% from a year earlier and +1% from the quarter before.
Was Repligen profitable in the first quarter 2025?
Operating profit was $6.6M (3.9% of revenue) and net earnings $5.8M.
Source: Repligen 10-Q on SEC EDGAR.